Ticker brief
DRMA
last close
·
1 day
·
14 days
·
mkt cap
·
signals 14d
5
authors 14d
3
crowd 14d
+0.3σ
No price history on file for this name (likely non-equity or unlisted) — the “since then” column below stays blank.
Sentiment — last 14 days
daily mean sentiment, 2026-08-17 → 2026-08-25 · now +0.30 (−1 bearish … +1 bullish)
Who spoke3
| author | grade | trader score | signals | mean sent |
|---|---|---|---|---|
| @AccesswireNews | C | · | 2 | +0.00 |
| @CrweWorld | C | · | 2 | -0.02 |
| @BiopharmIQ | B | · | 1 | -0.20 |
Recent signals5of 5 in 14d — receipts included
| date (PT) | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|
| 2026-08-25 | @CrweWorld | +0.30 | Dermata Therapeutics announced the commercial launch of Tome Foundational Treatment. | · | tweet ↗ |
| 2026-08-21 | @AccesswireNews | +0.25 | Dermata opened preorders for Tome Foundational Treatment ahead of commercial launch. | · | tweet ↗ |
| 2026-08-17 | @BiopharmIQ | -0.20 | Biotech news list reports FDA acceptance, positive trials, a merger, placement and severe data-related move. | · | tweet ↗ |
| 2026-08-17 | @CrweWorld | -0.35 | Dermata announced a $3.4 million at-the-market-priced private placement. | · | tweet ↗ |
| 2026-08-17 | @AccesswireNews | -0.25 | Dermata announced a $3.4M private placement priced at the market. | · | tweet ↗ |
“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.